The epoxide/diol profiles in the liver biopsied from patients with obesity corroborated these findings, suggesting an overall reduced sEH activity (increased 14,15-EET:DHET) when patients are stratified according to the occurrence of T2DM. The gene discussed is EPHX2; the disease is obesity disorder.